SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is surging following overwhelmingly positive Phase 2 S-OLARIS trial results for sonelokimab in axial spondyloarthritis, which showcased an 81% ASAS40 response rate and early signs of disease modification. The community is buzzing with extreme bullishness, citing these best-in-class results, robust financials, and anticipated short-covering as key drivers ahead of a highly awaited Investor Day.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. (DJT) is trending amidst community concerns over new global tariffs imposed by Donald Trump after the Supreme Court struck down previous ones, coupled with a filing that could allow Trump's trust to sell a substantial amount of stock, fueling fears of dilution and the stock's long-term viability.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is actively discussed as it pivots away from its planned company split and commits to a significant domestic investment, with community sentiment boosted by the new CEO's strategic direction, a substantial dividend yield, and potential benefits from recent Supreme Court tariff decisions.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as a new wave of 15% global tariffs enacted by Trump, following a Supreme Court decision, ignites fears of a market downturn among bears, while bulls remain hopeful for a swift reversal amidst broader economic uncertainty and an ongoing crypto sell-off.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

ProShares Short Bitcoin Strategy ETF ($BITI) is trending as community discussion links Jeffrey Epstein to early Bitcoin development, sparking strong bearish sentiment. Many traders are actively shorting Bitcoin, labeling it a 'pedo-currency' and expecting significant price drops.

Figure Technology Solutions, Inc. is a blockchain-native capital marketplace, which engages in connecting origination, funding, and secondary market activity. It operates through the following segments: FTI, Markets, and Other. The FTI segment offers Figure Connect which generates ecosystem and technology fees, and originates, sells, and securitizes home equity line of credit (HELOC) loans that it services. The Markets segment utilizes blockchain technology to develop an exchange for digital assets and credit, with new product offerings including providing interest-bearing stable coin deposits. The company was founded by Michael Scott Cagney and June Ou in 2018 and is headquartered in Reno, NV.

Figure Technology Solutions Inc. - Ordinary Shares - Class A

Figure Technology Solutions Inc

Figure Technology Solutions faces intense scrutiny and a sharp price decline, attributed by some to a major bank's downgrade and "pump and dump" concerns; meanwhile, a bullish segment of the community views the current dip as a generational buying opportunity for its blockchain-native lending platform ahead of expected strong earnings.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik (RBRK) is trending amidst a significant sell-off in the cybersecurity sector, largely triggered by initial market concerns over Anthropic's Claude Code Security, though many in the community argue RBRK, focused on post-breach recovery and resilience, has negligible exposure and could even benefit from increased AI-driven threats. Despite strong preliminary Q4 results and analysts maintaining buy ratings, the stock has been pressured by broader software valuation compression, creating a stark divide between those calling it 'garbage' and others seeing a 'buying opportunity' given its critical role in data security and robust fundamentals.

TOSHI

TOSHI is actively trending across the crypto community, driven by strong technical indicators pointing to an imminent breakout and a prevailing bullish sentiment for its role as a key memecoin within the Base ecosystem. Many investors are seizing current price levels, anticipating a substantial rally as altcoin season gains momentum.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending as its new fibromyalgia drug, Tonmya, shows robust early sales and expanding market access following its latest 8-K filing, attracting significant institutional investment. The community is widely discussing the drug's blockbuster potential and the company's undervaluation, even while some voice concerns over historical dilution and market manipulation.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is trending amid polarized discussion as bulls highlight its live mainnet, institutional validation via Coinbase, and long-term utility in Japan's regulated market. Bears, however, point to persistent price depreciation and recent news of a major partnership falling through, fueling debate over the project's viability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL Dosing Regimens

Alpha Cognition Inc. (NASDAQ: ACOG) (Alpha Cognition, ACI, or the Company), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today...

Alpha Cognition (NASDAQ:ACOG) Trading Up 13.3% - Here's What Happened

Alpha Cognition (NASDAQ:ACOG) Stock Price Up 13.3% - Should You Buy...

Alpha Cognition Inc. (NASDAQ:ACOG) Short Interest Update

Alpha Cognition Inc. (NASDAQ:ACOG - Get Free Report) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 250,001 shares, a growth of...

Alpha Cognition Inc. (NASDAQ:ACOG) Short Interest Up 60.0% in December

Alpha Cognition Inc. (NASDAQ:ACOG - Get Free Report) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totaling 167,235 shares, a...

Alpha Cognition (NASDAQ:ACOG) Given "Buy" Rating at HC Wainwright

HC Wainwright restated a "buy" rating and set a $18.00 price objective on shares of Alpha Cognition in a research report on Friday...

Alpha Cognition (NASDAQ:ACOG) Shares Down 5.6% - Time to Sell?

Alpha Cognition (NASDAQ:ACOG) Stock Price Down 5.6% - Here's What Happened...

Are Medical Stocks Lagging  Alpha Cognition Inc. (ACOG) This Year?

Here is how Alpha Cognition Inc. (ACOG) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.

Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners

Alpha Cognition Inc. (Nasdaq: ACOG) (Alpha Cognition or the Company), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that...

Is Alpha Cognition Inc. (ACOG) Stock Outpacing Its Medical Peers This Year?

Alpha Cognition (NASDAQ:ACOG) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of Alpha Cognition from a "sell" rating to a "hold" rating in a research report on Saturday...

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. It has additional pre-clinical development programs: ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease, ALPHA-1062 sublingual formulation, ALPHA-1062 intranasal (“ALPHA-1062IN”) formulation for the treatment of cognitive impairment with mild traumatic brain injury (mTBI, otherwise known as concussion) and ALPHA-0602, ALPHA-0702 & ALPHA-0802. The company was founded in 2000 and is headquartered in Grapevine, TX.

Current Price	$5.85
Prev Close	$5.85
Open	$5.85
Dividend Yield	0.00%
50-Day Moving Average	$5.70
Beta	0.00
Avg. Volume	58,204.15
PE Ratio	-4.28

52-Week High	$11.54
52-Week Low	$3.75
Market Capitalization	$127.19M
EPS (Annual)	-$2.02
Price to Book	2.80
Revenue Per Employee	N/A

ACOG
Alpha Cognition Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ACOG News

ACOGAlpha Cognition Inc